ESPR R&D Expense Growth
Esperion Therapeutics Inc · R&D Expense Growth
ESPR R&D Expense Growth
Latest reported3.49%period ending
ESPR FY R&D Growth (YoY) (0.00% → 3.49%)
Latest values, visible window
High-resolution chart · PNG
ESPR r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 3.4906% | |
| -46.3017% | |
| -27.5968% | |
| 12.2218% | |
| -27.8768% | |
| -16.3287% | |
| 2.4042% | |
| 16.1819% | |
| 155.0684% | |
| 94.1749% | |
| 17.7852% | |
| 57.9972% | |
| 100.2244% | |
| 2.439% | |
| 0% | |
| 2.503% | |
| -1.5375% | |
| 156.8208% | |
| 0% |